Measles, Mumps, Rubella Vaccine (Priorix; GSK-MMR): A Review of its Use in the Prevention of Measles, Mumps and Rubella

ISSN： 0012-6667

Source： Drugs, Vol.63, Iss.19, 2003-01, pp. : 2107-2126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Measles, mumps and rubella (MMR) vaccine appears to be highly effective in the military setting

Inpharma, Vol. 1, Iss. 1262, 2000-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

A post-marketing surveillance study has revealed no new evidence to suggest that the new measles mumps and rubella virus (MMR) vaccine [Priorix]

Reactions Weekly, Vol. 1, Iss. 1150, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Live Attenuated Measles, Mumps, Rubella, and Varicella Zoster Virus Vaccine (Priorix-Tetra ™ )

By Dhillon Sohita Curran Monique P.

Pediatric Drugs, Vol. 10, Iss. 5, 2008-01 ,pp. : 337-347

Adis International

Access to resources Recommend Favorite

Measles mumps and rubella virus vaccine: Encephalitis in paediatric patients: case report

Reactions Weekly, Vol. 1, Iss. 1336, 2011-01 ,pp. : 33-33

Adis International

Access to resources Recommend Favorite

Measles, mumps and rubella virus vaccine: Orchitis: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1302, 2010-01 ,pp. : 33-33

Adis International

Access to resources Recommend Favorite